Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Title slide and speaker credits
- Dolly
- Cloning of mammals raises complex questions
- Genomic reprogramming
- Epigenetic reprogramming of the genome
- Reprogramming in normal development
- Reprogramming in nuclear cloning
- NT to create patient-specific ES cells
- Video - enucleation of the egg
- Video - preparation of the doner nucleus
- Video - nuclear transfer into the egg
- Cleavage of cloned embryos
- What can be cloned
- Nuclear cloning is very Inefficient
- Loss of nuclear potency with Inc. age of donor
- High survival of clones from embryonic donor cells
- Problems in cloned animals
- Large offspring syndrome
- Donor nucleus and phenotype of cloned mice
- Expression profiling of cloned newborns
- Gene expression in cloned animals
- "Hidden" defects in cloned animals
- Degree of abnormalities in clones a continuum
- Problems of cloned animals are epigenetic
- Can nuclei from term. diff. cells be reprogrammed?
- Monoclonal mouse
- 2 Step procedure - generating monoclonal mouse
- IgH gene rearrangement in all tissues
- Three lessons from monoclonal mice
- Nuclear cloning: genetic vs. epigenetic changes
- The concept normal development - tumorigenesis
- Outline of the experiment
- Nuclear cloning and cancer
- The experiment with melanoma donor cells
- Melanoma derived ES cells form chimeric pup
- Chimera from melanoma donor derived ES cell
- Coat color and tumors in chimeras
- Reprogramming of cancer cell genome
- Coat color and tumors in chimeras
- Cancer cell phenotype:
- Lesson I: nuclear cloning and reprogramming
- Cloning of humans?
- Lessons from animal cloning
- Abnormalities in clones
- Degree of abnormalities in clones
- Nuclear transplantation and therapeutic potential
- Medical challenges
- Embryonic stem cells
- Transplantation medicine
- SCNT ("therapeutic cloning")
- Transplantation medicine
- Lesson II: therapeutic cloning will work, but..
- Problems with therapeutic SCNT
- "Customized" cells for tissue repair: two options
- Questions of cloning
- Can reproductive cloning be made safe?
- Fertilization creates epigenetic differences
- Does faulty reprogramming pose a problem
- ES cells have similar in vivo potential
- SUMMARY: reproductive/therapeutic cloning
- One key concern against therapeutic cloning:
- E.S. cells derived from IVF embryos vs. by SCNT
- Fertilized or cloned embryos - 3 possible fates
- The cloned embryo: some issues
- British solution
- Alternatives to embryonic stem cells?
- Stem cells: a developmental hierarchy
- Re-evaluation of plasticity
- "Customized" ES cells for therapy: options?
- Juxtapose the issues
- Acknowledgments
Topics Covered
- Transfer of somatic cell nuclei into enucleated oocytes for full term development of mammals
- genomic reprogramming
- the use of ES cells, terminally differentiated lymphoid cells, neurons and cancer cells as donors for nuclear transplantation
- use of Somatic Cell Nuclear Transfer (SCNT) for "therapeutic cloning"
- scientific evidence vs. moral arguments
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Jaenisch, R. (2015, September 21). Nuclear cloning, stem cells and epigenetic reprogramming [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/HGCU3842.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Rudolf Jaenisch has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Nuclear cloning, stem cells and epigenetic reprogramming
A selection of talks on Reproduction & Development
Transcript
Please wait while the transcript is being prepared...
0:00
Nuclear cloning, stem cells, and epigenetic reprogramming,
and the promise of this technology for customized tissue repair.
Rudolf Jaenisch, Whitehead Institute, MIT and Cambridge.
0:15
This is Dolly, the first cloned animal published no more than eight years ago.
0:22
The cloning of mammals raised a number of complex questions.
For example scientific questions,
why and how does this procedure work?
And more complex, should we use this technology for human applications?
This of course raises scientific, practical,
and importantly ethical, political, and other questions.
0:47
So the problem of nuclear cloning is genomic reprogramming.
In the case of Dolly, the donor cell was from the mammary gland.
These cells express the genes appropriate for mammary gland function,
not the genes which are important for embryonic development.
So the transplanted nucleus must activate these embryonic genes,
and that's where the problem is.
Only few clones manage to activate these genes,
and those which do manage to activate these genes are often not normal.
1:19
The key issue of nuclear cloning is the epigenetic reprogramming of the genome.
The problem is how to reset the adult pattern of gene expression of
the donor cell to an embryonic one which is appropriate for embryonic development.
First, you have to realize that reprogramming is
an important aspect of normal development. Let me illustrate
this. Epigenetic reprogramming in